New breast implant set for trials

	Tweet

A British firm has announced plans to develop breast implants using a synthetic biomaterial which it claims will make them safer and feel more natural.

Scottish-based AorTech said on Friday they were preparing to begin clinical trials of their “next generation” Elast-Eon implants following a recent meeting with the U.S. Food and Drug Administration.

"The take-away from the meeting is we’re on the right track,” AorTech chief executive Frank Maguire told Reuters.

“It makes all the sense in the world to move ahead and take it to the stage where we’re ready for clinical trials. This is the next generation.”

Elast-Eon was designed at the Commonwealth Scientific and Industrial Research Organization (CSIRO) in Melbourne, Australia, as a biostable material for use in life-critical medical devices such cardiovascular implants.

But AorTech said it hoped Elast-Eon would help them break into a global market in breast implants estimated to be worth $600 million a year.

Tear-resistant, flexible and blood-compatible, the material offers a more durable and resilient alternative to silicone or silicone gel.

Silicone implants, which were first developed in the 1960s, were taken off the market in the U.S. in 1993 due to concerns over their safety.

Critics claim silicone often leaks from the gel-filled devices, causing cancer and neurological diseases.

As a result more than 90 percent of the U.S. market now uses saline-filled implants. To prevent leaching and rupturing, breast implants have become increasingly firm, while trials with peanut oil and soy-bean oil have failed to produce a satisfactory alternative.

In January the U.S. Food and Drug Administration rejected a manufacturer’s request to restore silicone breast implants to the market.

“Now they’re too firm,” said Maguire. “And saline implants are like bags of water.

“Elast-Eon is a very clean material that is free of the silicone oil that has been leaching out of gel-filled devices for the past 20 to 30 years. And we can move back into the softer range that more naturally simulates breast tissue.”

AorTech said Elast-Eon was also more compatible with imaging technology used in tumor screening.

Earlier this year the Journal of the American Medical Association published research which claimed that breast implants made it harder for doctors to interpret mammograms.

RELATED STORIES:
Doctors begin to separate “mermaid” baby’s legs   Obese patients less likely to develop and die from respiratory distress syndromes after surgery   Being heavy cuts angioplasty complications   Study Shows Surgery Is More Effective Than Other Treatments for Common Back Problem   Study identifies racial and ethnic disparities in surgical care   Jefferson doctors strengthen case for high-dose radiotherapy technique after radical prostatectomy   Monitor may stop patient awareness during surgery   Laser surgery ‘remodels’ tissue under aging skin   Surgery often unnecessary for low back pain   Surgeons General, STOP Obesity Alliance announce America has reached tipping point on obesity   Surgeons Perform Mid-south’s First Robotic Hysterectomy   Woman gets near-total face transplant in Cleveland

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]